GLRA1
MOLECULAR TARGETglycine receptor alpha 1
GLRA1 (glycine receptor alpha 1) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting GLRA1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Strychnine | 3.30 | 26 |
| 2 | Adapalene | 0.69 | 1 |
| 3 | Astemizole Antihistamine drug now withdrawn from | 0.69 | 1 |
| 4 | Cholecalciferol Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of | 0.69 | 1 |
| 5 | cinacalcet | 0.69 | 1 |
| 6 | Colchicine | 0.69 | 1 |
| 7 | Dutasteride | 0.69 | 1 |
| 8 | Fluspirilene | 0.69 | 1 |
| 9 | Picrotoxin | 0.69 | 1 |
| 10 | Sulindac | 0.69 | 1 |
About GLRA1 as a Drug Target
GLRA1 (glycine receptor alpha 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented GLRA1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
GLRA1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.